PGR and triple-negative breast carcinoma: The established human cell lines from breast cancer MCF-7 (estrogen and progesterone receptor positive invasive ductal carcinoma), T-47D (progesterone receptor positive invasive ductal carcinoma) and MDA-MB231 (triple negative breast cancer) were used and provided by the pharmacology laboratory of NCI (National Cancer Institute, NIH, Frederick, MD, USA).